The search for new solid forms of existing materials offers the potential to perturb properties such as solubility without additional synthesis and the associated costs and regulatory scrutiny. This is especially true in the area of pharmaceutical polymorphism, where performance and intellectual property concerns motivate the discovery of all energetically accessible arrangements of an API. Salt forms and cocrystals offer additional formulation possibilities to address solubility concerns in drug delivery.
Contact us to discuss your solid form screening needs and how ChemXLerate can be your partner in navigating solid form space.
services@chemxlerate.com
ChemXLerate LLC
2232 South Main St. #112
Ann Arbor, MI 48103-6938
(734) 388-8722
